CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 302 enrolled
Drug / intervention
complex treatmentother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04049006
NCT04049006N/ACompleted

Primary Care as a Promoter of the Quality of Life of Fibromyalgia Patients. Effectiveness and Cost-utility of a Complex Intervention Through a Randomized Clinical Trial

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina·interventional·Posted Aug 7, 2019·Updated Sep 7, 2023

In Brief

A clinical study evaluating complex treatment for Fibromyalgia. Completed, enrolled 302 participants across 1 site.

Detailed Summary

Fibromyalgia (FM) is a chronic disease characterized by chronic pain, fatigue and loss of function that leads to a significant deterioration in the quality of life. Despite controversies about the most appropriate treatment, studies indicate that a multidisciplinary treatment would be effective. This study aims to analyze the effectiveness and cost-utility of a complex intervention in the quality of life (main variable), the functional impact, the mood and the pain of people with FM treated in the Primary Care Teams (PCTs) of the Catalan Institute of Health (CIH).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFibromyalgia
CountriesSpain

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedAug 7, 2019
Enrollment StartApr 1, 2019
Primary CompletionMar 31, 2021
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 6.9 years ago

Interventions

complex treatmentother

The complex treatment will be based on health education, aerobic physical exercise and cognitive-behavioral therapy, during 12 weeks in sessions of 2 hours/week. The sessions will be conducted in the primary health care by trained professionals.